₹325.9
▼ -15.25 -4.47%
17 Jul 2026
NSE Listed · Healthcare
ASM 1Suven Life Sciences Ltd. (SUVEN)
Volume: 11,06,401Avg Vol 1W: 4,79,329Avg Vol 1M: 12,98,19152W Range:₹124.11₹371
Key Ratios
Checked just nowMarket Cap₹9,209 Cr
Current Price₹325.9
Previous Close₹341.15
High / Low (52w)₹371 / ₹124.11
Volume11,06,401
Avg Vol (1W)4,79,329
Avg Vol (1M)12,98,191
Stock P/E—
Book Value₹29.74
Dividend Yield0%
ROE-46.73%
ROA-44.27%
Revenue (TTM)—
Revenue Growth-43.08%
Profit Margin-3,881.32%
Total Debt₹0 Cr
Shares Outstanding28 Cr
Face Value₹1
EPS (TTM)₹0
P/B10.96
Debt / Equity0
50 DMA₹299.58
200 DMA₹220.38
Day change-4.47%
SurveillanceASM 1 (as of 2026-07-17)
Price Chart
₹325.9▲ 93.23% · 1Y
2025-11-242026-07-17
20-day avg volume: 8.6L shares
Pros
- Company is almost debt-free.
Cons
- Revenue fell 47% YoY.
- Company is loss-making at the latest annual result.
Quarterly Results
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹3 Cr | ₹2 Cr |
| EBITDA | ₹-28 Cr | ₹-50 Cr | ₹-39 Cr | ₹-44 Cr | ₹-52 Cr | ₹-77 Cr | ₹-102 Cr | ₹-45 Cr |
| Net Profit | ₹-28 Cr | ₹-50 Cr | ₹-39 Cr | ₹-44 Cr | ₹-52 Cr | ₹-77 Cr | ₹-102 Cr | ₹-46 Cr |
| EPS | — | — | — | — | — | — | — | — |
Profit & Loss (Annual)
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹649 Cr | ₹313 Cr | ₹28 Cr | ₹21 Cr | ₹13 Cr | ₹22 Cr | ₹33 Cr | ₹18 Cr |
| EBITDA | ₹200 Cr | ₹2 Cr | ₹-106 Cr | ₹-77 Cr | ₹-125 Cr | ₹-124 Cr | ₹-113 Cr | ₹-161 Cr |
| Net Profit | ₹124 Cr | ₹-24 Cr | ₹-94 Cr | ₹-72 Cr | ₹-122 Cr | ₹-118 Cr | ₹-105 Cr | ₹-161 Cr |
| EPS | 9.72 | -1.88 | -7.4 | -5.67 | -9.05 | -5.42 | -4.82 | -7.37 |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹919 Cr | ₹303 Cr | ₹182 Cr | ₹128 Cr | ₹108 Cr | ₹389 Cr | ₹285 Cr | ₹135 Cr |
| Total Liabilities | ₹152 Cr | ₹64 Cr | ₹39 Cr | ₹20 Cr | ₹12 Cr | ₹14 Cr | ₹15 Cr | ₹25 Cr |
| Equity | ₹767 Cr | ₹239 Cr | ₹143 Cr | ₹108 Cr | ₹96 Cr | ₹375 Cr | ₹270 Cr | ₹110 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating | ₹113 Cr | ₹-38 Cr | ₹-132 Cr | ₹-95 Cr | ₹-127 Cr | ₹-115 Cr | ₹-122 Cr | ₹-155 Cr |
| Investing | ₹-1 Cr | ₹37 Cr | ₹146 Cr | ₹56 Cr | ₹-22 Cr | ₹-248 Cr | ₹94 Cr | ₹155 Cr |
| Financing | ₹-52 Cr | ₹5 Cr | ₹3 Cr | ₹35 Cr | ₹146 Cr | ₹396 Cr | ₹-1 Cr | ₹-1 Cr |
| Free Cash Flow | ₹113 Cr | ₹-38 Cr | ₹-132 Cr | ₹-95 Cr | ₹-127 Cr | ₹-115 Cr | ₹-122 Cr | ₹-155 Cr |
Shareholding
Promoter 70.15% Institutions 5.53% Public 24.32%
Efficiency & Working Capital
ROCE-45.4%
Interest Coverage-944.6
Dividend Payout—
Debtor Days73 d
Inventory Days13 d
Payable Days287 d
Cash Conversion Cycle-200 d
Working Capital Days86 d
Shareholding Details
As of 2026-03-31
Promoter70.2%
FII0.9%
DII4.6%
Institutions5.5%
Public24.3%
Promoter Pledge0%
No. of Shareholders63,915
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Jul 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.6% | 69.6% | 70.3% | 70.3% | 70.3% | 70.3% | 70.3% | 67.4% | 67.4% | 67.4% | 67.4% | 70.2% |
| FIIs | 0.5% | 0.5% | 0.4% | 0.3% | 0.3% | 0.3% | 0.6% | 0.6% | 0.6% | 1.2% | 1.1% | 0.9% |
| DIIs | 0.1% | 1.2% | 1.2% | 1.1% | 1.1% | 0% | 0% | 3.4% | 3.4% | 3.4% | 3.4% | 4.6% |
| Public | 29.8% | 28.8% | 28.1% | 28.3% | 28.3% | 29.5% | 29.1% | 28.6% | 28.6% | 28.1% | 28.2% | 24.3% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 74,003 | 68,959 | 66,116 | 63,975 | 63,537 | 64,603 | 66,159 | 65,574 | 65,574 | 64,921 | 64,381 | 63,915 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Jasti Property And Equity Holdings Private Limited (in Its Capacity As Sole Trustee Of Jasti Family | Shareholding of Promoter and Promoter Group | 69.6% | 18.35 Cr |
| Quant Mutual Fund - Quant Small Cap Fund | Public Shareholding | 1.8% | 47,01,490 |
| 3p India Equity Fund 1 | Public Shareholding | 1.3% | 33,58,209 |
| Abakkus Diversified Alpha Fund | Public Shareholding | 1.1% | 29,85,000 |
| Sudharani Jasti | Shareholding of Promoter and Promoter Group | 0.6% | 15,28,535 |
| Kalyani Jasti | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
| Sirisha Jasti | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
| Madhavi Jasti | Shareholding of Promoter and Promoter Group | 0% | 1,000 |
| Venkateswarlu Jasti | Shareholding of Promoter and Promoter Group | 0% | 2,201 |
Promoter Pledges
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Venkateswarlu Jasti | 0 | 0% | 2026-03-31 |
| Sudharani Jasti | 0 | 0% | 2026-03-31 |
| Kalyani Jasti | 0 | 0% | 2026-03-31 |
| Sirisha Jasti | 0 | 0% | 2026-03-31 |
| Madhavi Jasti | 0 | 0% | 2026-03-31 |
| Jasti Property And Equity Holdings Private Limited (in Its Capacity As Sole Trustee Of Jasti Family | 0 | 0% | 2026-03-31 |
| Quant Mutual Fund - Quant Small Cap Fund | 0 | 0% | 2026-03-31 |
| 3p India Equity Fund 1 | 0 | 0% | 2026-03-31 |
| Abakkus Diversified Alpha Fund | 0 | 0% | 2026-03-31 |
| Venkateswarlu Jasti | 0 | 0% | 2025-12-31 |
| Sudharani Jasti | 0 | 0% | 2025-12-31 |
| Kalyani Jasti | 0 | 0% | 2025-12-31 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Venkateswarlu Jasti | Chairman / Executive Director / M D / Promoter | 2025 |
| Sudha Rani Jasti | WTD & Executive Director | 2025 |
| Seyed E Hasnain | Non Executive Director | 2025 |
| Santanu Mukherjee | Independent Non Exe. Director | 2025 |
| J A S Padmaja | Independent Non Exe. Director | 2025 |
| Vajja Sambasiva Rao | Independent Non Exe. Director | 2025 |
| Sangeetha Laxmi Kandari | Company Sec. & Compli. Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing (CRAMS) | ₹614 Cr | 92.5% |
| Services (DDDSS) | ₹50 Cr | 7.5% |
| Research and Development | ₹0 Cr | 0% |
Segments — Geography
| Region | Revenue | Share |
|---|---|---|
| INDIA | ₹5 Cr | 71.1% |
| U S A | ₹0 Cr | 0.9% |
| EUROPE | ₹0 Cr | 5.2% |
| OTHERS | ₹2 Cr | 22.7% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹1 | 30 | 22 | 22 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 114 | 0 | 0 | 1 | 0 | 115 |
| 2025 | 114 | 0 | 0 | 0 | 0 | 114 |
| 2025 | 0 | 0 | 0 | 1 | 0 | 1 |
Insider / Designated-Person Trades
3 recent disclosure(s)
Jasti Property and Equity Holdings Private Limited in its capacity as sole trustee of Jasti Family TrustAcquisition · 3,17,68,764
SUDHARANI JASTIAcquisition · 15,25,535
Jasti Property and Equity Holdings Private Limited in its capacity as sole trustee of the Jasti Family TrustAcquisition · 1,81,00,000
Substantial Acquisitions (SAST)
1 disclosure(s)
Transmission28/05/2024 · 15,25,535
Company Information
Incorporated1989
ChairmanVenkateswarlu Jasti
AuditorKarvy & Co
Investor Email[email protected]; [email protected]
📍 #8-2-334 SDE Serene Chambers, 6 th Floor Road No 5 Avenue 7, Hyderabad, Telangana, 500034
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Suryalata Spinning Mill LimitedSuryalakshmi Cot Mil Ltd.Surya Roshni Ltd.Suryoday Small Fin Bk Ltd.Susan Electricals India LimitedSutlej Text & Indus Ltd.Suvidhaa Infoserve Ltd.Suyog Telematics LimitedSuzlon Energy LimitedShree Vasu Logistics Ltd.SVP Global Textiles Ltd.Swan Corp LimitedAll “S” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search